Navigation Links
Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
Date:1/27/2011

e obtained at the SEC's website at www.sec.gov or from Roth Capital Partners, LLC by e-mail to rothecm@roth.com or by mail to 1787 Sentry Parkway West, Building 18, Suite 400, Blue Bell, Pennsylvania 19422.

About Inovio Pharmaceuticals, Inc.Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. These SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio's clinical programs include HPV/cervical dysplasia and cancer (therapeutic), avian flu (preventive), and HIV vaccines (both preventive and therapeutic). Inovio is developing universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, National Microbiology Laboratory of the Public Health Agency of Canada, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... July 4, 2015 Añadir ... quimioterapia de primera línea para pacientes con cáncer ... extiende la supervivencia libre de progresión en ese ... metastásico no resecable (mCRC) que se ha propagado ... la supervivencia libre de progresión (PFS) en el ...
(Date:7/4/2015)... 4, 2015 De ... chemotherapie voor patiënten met niet-resectabele uitgezaaide colorectale ... progressievrije overleving in dat orgaan. ... (mCRC) die alleen binnen de lever is ... overleving (PFS) in de lever dankzij de ...
(Date:7/4/2015)... , July 4, 2015 ... for patients with unresectable metastatic colorectal cancer in ... that organ Patients with unresectable metastatic ... the liver experienced the greatest improvement in Progression-Free ... of SIR-Spheres Y-90 resin microspheres to a current ...
Breaking Medicine Technology:El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4
... , LOS ANGELES , June 1 One minute ... their two dogs. The next, they had shattered legs and pelvises and one of ... horrifying impact, leaving them to put the pieces of their lives back together. ... In the nearly two years since ...
... CareFusion (NYSE: CFN ), a leading, ... Closed Loop Controller of Inspired Oxygen system or "CLiO2™," the ... the oxygen level in the blood within a safe range ... an enhancement to the CareFusion AVEA™ ventilator, one of the ...
Cached Medicine Technology:The SCOOTER Store Donates Scooter to Hit-and-Run Accident Victim 2The SCOOTER Store Donates Scooter to Hit-and-Run Accident Victim 3CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation 2CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation 3
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently running a promotion ... of celebrities will have the opportunity to get 10% discount on orders that are ... do not have to use coupon codes or remember redemption codes. , There ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... Lone Star State. The premium frozen yogurt chain was listed as #22 on the ... July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite 200, ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking ... the University of Minnesota, they knew it would save the university energy and ... award-winning choice: the total energy savings after installation was an impressive 89 percent, ...
(Date:7/2/2015)... Bolingbrook, IL (PRWEB) , ... July 02, 2015 , ... In 2012, Patrick Achebe realized ... when he was alone. He sat down to write his first poem, and three years ... of him that was special and worth sharing with the world. "I have always believed ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready to hit the ... Since the socks were first introduced, they have rapidly been gaining attention among ... four new, fun shades including: blue, lime, pink and red. , Utilizing ...
Breaking Medicine News(10 mins):Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2
... - Gross new business awards of $664 million for the year represent growth ... - Record total business authorizations of $869 million represent an, increase of 32% from ... ... up more than 600 basis points from 2006 ...
... Nation,s largest not-for-profit home health care agency turns to ... ... Wireless (Booth,#8163), a leading provider of mobile productivity and management software,announced ... by the Visiting Nurse Service of New York (VNSNY) to provide,VNSNY,s ...
... Overweight Hispanic children with normal blood glucose (sugar) levels ... them to developing both type 2 diabetes and cardiovascular disease, ... Diabetes Center. , The study, published in the March issue ... children, already known to be at high risk for developing ...
... Fight Against Cancer, CLEVELAND, Feb. 26 ... for a final debate before the March 4,primaries. ... the,American public but fell short on a critical ... issue identified by 62 percent of Americans as ...
... John Williams,a shrimp fisherman and executive director ... House Subcommittee on Oversight and,Investigations of the Commerce ... the Food and Drug Administration,s,(FDA) reliance on importers ... actions., "On behalf of the U.S. shrimp ...
... boundaries of the well-known song My Favorite Things at the ... what inspired him to take the musical turns he took. ... how the brain was helping to carry him there. Scientists ... Disorders (NIDCD) have found that, when jazz musicians are engaged ...
Cached Medicine News:Health News:Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008 2Health News:Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008 3Health News:Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008 4Health News:Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008 5Health News:Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008 6Health News:Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008 7Health News:Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008 8Health News:Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008 9Health News:NetMotion Wireless Boosts Mobile Productivity for Visiting Nurse Service of New York 2Health News:NetMotion Wireless Boosts Mobile Productivity for Visiting Nurse Service of New York 3Health News:Overweight Hispanic children shown to have vascular inflammation 2Health News:Democratic Candidates Miss Key Health Issue in Debate 2Health News:Testimony to Congress Denounces FDA Reliance on Self-Policing 2Health News:In jazz improv, large portion of brain's prefrontal region 'takes 5' to let creativity flow 2Health News:In jazz improv, large portion of brain's prefrontal region 'takes 5' to let creativity flow 3Health News:In jazz improv, large portion of brain's prefrontal region 'takes 5' to let creativity flow 4
... family of infrared laser photocoagulators includes the ... diode lasers serve as a single laser ... require no regular maintenance or special electrical/cooling, ... design. The OcuLight SLx is now available ...
... is the least expensive of the series. It has ... central area of the cornea. The model comes with ... a picture of a patients corneal endothelium, you simply ... on the chin rest. The left side of the ...
... permeable contact lenses used for corneal refractive ... (myopia). The patient wears the lenses overnight ... During the day, nearsightedness is corrected or ... RG contact lenses apply slight pressure to ...
... the major challenges to operating your ... market fee for each procedure includes:, ... requirements., Board Certified Nuclear Medicine Technologist., ... Hot Lab Equipment and Accessories., All ...
Medicine Products: